Copyright Reports & Markets. All rights reserved.

Global Traveler's Diarrhea Therapeutics Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Traveler's Diarrhea Therapeutics Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Traveler's Diarrhea Therapeutics Market Size Growth Rate by Type
    • 1.4.2 Immunization
    • 1.4.3 Non-antibiotic Agents
    • 1.2.4 Antibiotics
    • 1.2.5 Anti-Motility Agents
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Traveler's Diarrhea Therapeutics Market Size Growth Rate by Application
    • 1.3.2 Adult Traveler's Diarrhea
    • 1.3.3 Children Traveler's Diarrhea
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Traveler's Diarrhea Therapeutics Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Traveler's Diarrhea Therapeutics Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Traveler's Diarrhea Therapeutics Regions by Sales
    • 2.4.1 Global Top Traveler's Diarrhea Therapeutics Regions by Sales (2016-2021)
    • 2.4.2 Global Top Traveler's Diarrhea Therapeutics Regions by Sales (2022-2027)
  • 2.5 Global Top Traveler's Diarrhea Therapeutics Regions by Revenue
    • 2.5.1 Global Top Traveler's Diarrhea Therapeutics Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Traveler's Diarrhea Therapeutics Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Traveler's Diarrhea Therapeutics Sales by Manufacturers
    • 3.1.1 Global Top Traveler's Diarrhea Therapeutics Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Traveler's Diarrhea Therapeutics Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Traveler's Diarrhea Therapeutics Sales in 2020
  • 3.2 Global Traveler's Diarrhea Therapeutics Revenue by Manufacturers
    • 3.2.1 Global Top Traveler's Diarrhea Therapeutics Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Traveler's Diarrhea Therapeutics Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Traveler's Diarrhea Therapeutics Revenue in 2020
  • 3.3 Global Traveler's Diarrhea Therapeutics Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Traveler's Diarrhea Therapeutics Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Traveler's Diarrhea Therapeutics Sales by Type
    • 4.1.1 Global Traveler's Diarrhea Therapeutics Historical Sales by Type (2016-2021)
    • 4.1.2 Global Traveler's Diarrhea Therapeutics Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2027)
  • 4.2 Global Traveler's Diarrhea Therapeutics Revenue by Type
    • 4.2.1 Global Traveler's Diarrhea Therapeutics Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Traveler's Diarrhea Therapeutics Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2016-2027)
  • 4.3 Global Traveler's Diarrhea Therapeutics Price by Type
    • 4.3.1 Global Traveler's Diarrhea Therapeutics Price by Type (2016-2021)
    • 4.3.2 Global Traveler's Diarrhea Therapeutics Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Traveler's Diarrhea Therapeutics Sales by Application
    • 5.1.1 Global Traveler's Diarrhea Therapeutics Historical Sales by Application (2016-2021)
    • 5.1.2 Global Traveler's Diarrhea Therapeutics Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2027)
  • 5.2 Global Traveler's Diarrhea Therapeutics Revenue by Application
    • 5.2.1 Global Traveler's Diarrhea Therapeutics Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Traveler's Diarrhea Therapeutics Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2016-2027)
  • 5.3 Global Traveler's Diarrhea Therapeutics Price by Application
    • 5.3.1 Global Traveler's Diarrhea Therapeutics Price by Application (2016-2021)
    • 5.3.2 Global Traveler's Diarrhea Therapeutics Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Traveler's Diarrhea Therapeutics Market Size by Type
    • 6.1.1 North America Traveler's Diarrhea Therapeutics Sales by Type (2016-2027)
    • 6.1.2 North America Traveler's Diarrhea Therapeutics Revenue by Type (2016-2027)
  • 6.2 North America Traveler's Diarrhea Therapeutics Market Size by Application
    • 6.2.1 North America Traveler's Diarrhea Therapeutics Sales by Application (2016-2027)
    • 6.2.2 North America Traveler's Diarrhea Therapeutics Revenue by Application (2016-2027)
  • 6.3 North America Traveler's Diarrhea Therapeutics Market Size by Country
    • 6.3.1 North America Traveler's Diarrhea Therapeutics Sales by Country (2016-2027)
    • 6.3.2 North America Traveler's Diarrhea Therapeutics Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Traveler's Diarrhea Therapeutics Market Size by Type
    • 7.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Type (2017-2027)
    • 7.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Type (2017-2027)
  • 7.2 Europe Traveler's Diarrhea Therapeutics Market Size by Application
    • 7.2.1 Europe Traveler's Diarrhea Therapeutics Sales by Application (2017-2027)
    • 7.2.2 Europe Traveler's Diarrhea Therapeutics Revenue by Application (2017-2027)
  • 7.3 Europe Traveler's Diarrhea Therapeutics Market Size by Country
    • 7.3.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2017-2027)
    • 7.3.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Type
    • 8.1.1 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Application
    • 8.2.1 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Region
    • 8.3.1 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Traveler's Diarrhea Therapeutics Market Size by Type
    • 9.1.1 Latin America Traveler's Diarrhea Therapeutics Sales by Type (2019-2027)
    • 9.1.2 Latin America Traveler's Diarrhea Therapeutics Revenue by Type (2019-2027)
  • 9.2 Latin America Traveler's Diarrhea Therapeutics Market Size by Application
    • 9.2.1 Latin America Traveler's Diarrhea Therapeutics Sales by Application (2019-2027)
    • 9.2.2 Latin America Traveler's Diarrhea Therapeutics Revenue by Application (2019-2027)
  • 9.3 Latin America Traveler's Diarrhea Therapeutics Market Size by Country
    • 9.3.1 Latin America Traveler's Diarrhea Therapeutics Sales by Country (2019-2027)
    • 9.3.2 Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Type
    • 6.1.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Application
    • 6.2.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country
    • 6.3.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Salix Pharmaceuticals
    • 11.1.1 Salix Pharmaceuticals Corporation Information
    • 11.1.2 Salix Pharmaceuticals Overview
    • 11.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Description
    • 11.1.5 Salix Pharmaceuticals Related Developments
  • 11.2 P&G
    • 11.2.1 P&G Corporation Information
    • 11.2.2 P&G Overview
    • 11.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 P&G Traveler's Diarrhea Therapeutics Product Description
    • 11.2.5 P&G Related Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Overview
    • 11.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Description
    • 11.3.5 Johnson & Johnson Related Developments
  • 11.4 Otsuka Pharma
    • 11.4.1 Otsuka Pharma Corporation Information
    • 11.4.2 Otsuka Pharma Overview
    • 11.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Description
    • 11.4.5 Otsuka Pharma Related Developments
  • 11.5 Valneva
    • 11.5.1 Valneva Corporation Information
    • 11.5.2 Valneva Overview
    • 11.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Valneva Traveler's Diarrhea Therapeutics Product Description
    • 11.5.5 Valneva Related Developments
  • 11.6 Shanghai United Cell
    • 11.6.1 Shanghai United Cell Corporation Information
    • 11.6.2 Shanghai United Cell Overview
    • 11.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Description
    • 11.6.5 Shanghai United Cell Related Developments
  • 11.7 PaxVax
    • 11.7.1 PaxVax Corporation Information
    • 11.7.2 PaxVax Overview
    • 11.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 PaxVax Traveler's Diarrhea Therapeutics Product Description
    • 11.7.5 PaxVax Related Developments
  • 11.8 Livzon
    • 11.8.1 Livzon Corporation Information
    • 11.8.2 Livzon Overview
    • 11.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Livzon Traveler's Diarrhea Therapeutics Product Description
    • 11.8.5 Livzon Related Developments
  • 11.9 Immuron
    • 11.9.1 Immuron Corporation Information
    • 11.9.2 Immuron Overview
    • 11.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Immuron Traveler's Diarrhea Therapeutics Product Description
    • 11.9.5 Immuron Related Developments
  • 11.1 Salix Pharmaceuticals
    • 11.1.1 Salix Pharmaceuticals Corporation Information
    • 11.1.2 Salix Pharmaceuticals Overview
    • 11.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Description
    • 11.1.5 Salix Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Traveler's Diarrhea Therapeutics Value Chain Analysis
  • 12.2 Traveler's Diarrhea Therapeutics Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Traveler's Diarrhea Therapeutics Production Mode & Process
  • 12.4 Traveler's Diarrhea Therapeutics Sales and Marketing
    • 12.4.1 Traveler's Diarrhea Therapeutics Sales Channels
    • 12.4.2 Traveler's Diarrhea Therapeutics Distributors
  • 12.5 Traveler's Diarrhea Therapeutics Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Traveler's Diarrhea Therapeutics Industry Trends
  • 13.2 Traveler's Diarrhea Therapeutics Market Drivers
  • 13.3 Traveler's Diarrhea Therapeutics Market Challenges
  • 13.4 Traveler's Diarrhea Therapeutics Market Restraints

14 Key Findings in The Global Traveler's Diarrhea Therapeutics Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Traveler's Diarrhea Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Traveler's Diarrhea Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Immunization
    Non-antibiotic Agents
    Antibiotics
    Anti-Motility Agents
    Others

    Segment by Application
    Adult Traveler's Diarrhea
    Children Traveler's Diarrhea

    By Company
    Salix Pharmaceuticals
    P&G
    Johnson & Johnson
    Otsuka Pharma
    Valneva
    Shanghai United Cell
    PaxVax
    Livzon
    Immuron

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now